Publication date:
30 November 2022
Supplementary analysis produced to support Cabinet’s decision to introduce the Therapeutic Products Bill to Parliament in 2022.
Reforms to the Public Service Act 2020 and the Pae Ora (Healthy Futures) Act 2022 has necessitated a reassessment of previous options for the entity form of the therapeutic products regulator.
This also includes reconsidering how the regulator is to be funded, in the context of optimising outcomes for the new therapeutic product regulatory regime.